ATHN up +0.48% percent Today $ATHN High is at 126.46 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
ATHN up +0.48% percent Today $ATHN High is at 126.46 and the Low 123.00 with current volume of 143,794.

Recent News posted below.

Athenahealth ATHN other info.
http://investorshangout.com/Athenahealth-ATHN-53409/

ATHN Athenahealth Recent Headline News

Comparing America's 3 Largest Healthcare Information Services Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 10, 9:42AM CST

VEEV: 28.70 (+0.27), CERN: 63.21 (+0.20), ATHN: 123.34 (-0.48)

Allscripts Healthcare: Blue Harbour Group Won't Go Lightly
Marshall Hargrave - at Seeking Alpha - Wed Nov 05, 12:39PM CST

MDRX: 11.25 (-0.29), CERN: 63.21 (+0.20), ATHN: 123.34 (-0.48)

Alere (ALR) Lags Q3 Earnings, Revenues; Outlook Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 12:40PM CDT
Alere Inc. (ALR) reported disappointing third-quarter 2014 results as both the top and the bottom line missed the Zacks Consensus Estimate by a wide margin
BIO: 111.14 (+0.54), ALR: 39.38 (+0.01), CERN: 63.21 (+0.20), ATHN: 123.34 (-0.48)

11.7% Return Seen to Date on SmarTrend athenahealth Call (ATHN)
Comtex SmarTrend(R) - Mon Oct 27, 10:02AM CDT
SmarTrend identified a Downtrend for athenahealth (NASDAQ:ATHN) on September 15th, 2014 at $132.36. In approximately 1 month, athenahealth has returned 11.68% as of today's recent price of $116.90.
ATHN: 123.34 (-0.48)

Cerner Sees In-Line Q3 Earnings but Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:50AM CDT
For the fourth quarter of 2014, Cerner Corporation (CERN) anticipates revenues between $880 and $915 million
QSII: 14.58 (+0.02), MDRX: 11.25 (-0.29), CERN: 63.21 (+0.20), ATHN: 123.34 (-0.48)

Agreements, Financial Results, Upcoming Conference Calls, Analysis Results, and Technical Updates - Research Reports on SunEdison, Avago, LinkedIn, Equinix and athenahealth
PR Newswire - Wed Oct 22, 7:45AM CDT
Today, Analysts Review released its research reports regarding SunEdison, Inc. (NYSE: SUNE), Avago Technologies Limited (NASDAQ: AVGO), LinkedIn Corporation (NYSE: LNKD), Equinix, Inc. (NASDAQ: EQIX) and athenahealth, Inc. (NASDAQ: ATHN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7364-100free.
EQIX: 217.44 (+3.41), LNKD: 229.88 (+6.84), SUNE: 18.09 (+0.03), AVGO: 85.72 (+0.68), ATHN: 123.34 (-0.48)

Einhorn: Selloff Created Buying Opportunities, Embrace Higher Interest
at The Street - Tue Oct 21, 2:09PM CDT
The trading panels hosts hedge fund manager David Einhorn and looks at what to make of earnings from Coca-Cola, McDonald's and Chipotle.
KO: 42.33 (+0.01), CCI: 79.73 (-0.07), MU: 33.00 (-0.01), VRX: 127.76 (+1.65), WWE: 13.10 (-0.17), SPWR: 30.35 (+0.13), INTC: 33.22 (-0.36), ATHN: 123.34 (-0.48), AGN: 195.23 (-0.77), NFLX: 387.15 (+2.99), FIG: 7.32 (unch), SUNE: 18.09 (+0.03), TXN: 51.54 (+0.64), CMG: 648.26 (-0.77), AAL: 43.78 (+0.58), MCD: 95.15 (+0.05), AAPL: 108.95 (-0.06)

athenahealth Q3 Earnings Fall but Beat Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 20, 9:30AM CDT
For the full year 2014, athenahealth (ATHN) reiterated its revenues guidance of $725 to $755 million
ZLTQ: 27.60 (+0.11), GWPH: 73.90 (-0.07), OMCL: 32.45 (+0.56), ATHN: 123.34 (-0.48)

athenahealth Has Returned 14.2% Since SmarTrend Recommendation (ATHN)
Comtex SmarTrend(R) - Mon Oct 20, 9:26AM CDT
SmarTrend identified a Downtrend for athenahealth (NASDAQ:ATHN) on September 15th, 2014 at $132.36. In approximately 1 month, athenahealth has returned 14.25% as of today's recent price of $113.50.
ATHN: 123.34 (-0.48)

athenahealth Set to Possibly Rebound After Yesterday's Selloff of 7.25%
Comtex SmarTrend(R) - Fri Oct 17, 4:32PM CDT
athenahealth (NASDAQ:ATHN) traded in a range yesterday that spanned from a low of $107.88 to a high of $117.56. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $117.75 on volume of 2.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ATHN: 123.34 (-0.48)

GE and Urban Outfitters are big market movers
AP - Fri Oct 17, 3:31PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
URBN: 30.52 (-0.66), GE: 26.46 (+0.05), CLV: 10.65 (-0.12), RPRX: 9.30 (-0.82), CLF: 11.19 (+0.02), ATHN: 123.34 (-0.48), MS: 35.79 (+0.13)

Stocks Up Big Friday, Recover Early Week Losses
at Investor's Business Daily - Fri Oct 17, 3:24PM CDT
Stocks finished with big gains Friday, posting their best day in six sessions. Blue chips led, with the Dow Jones industrial average rising 1.6%, while the S&P 500 climbed 1.3% and the Nasdaq finished 1.0% higher. Preliminary data show volume coming...
VRX: 127.76 (+1.65), GILD: 106.80 (+0.35), AKRX: 35.88 (-0.71), CMG: 648.26 (-0.77), ILMN: 188.45 (+2.10), DIS: 89.69 (-0.31), AAPL: 108.95 (-0.06), ATHN: 123.34 (-0.48)

What's Behind Athenahealth's So-So Earnings
Keith Speights, The Motley Fool - Motley Fool - Fri Oct 17, 1:14PM CDT
Investors looking for a return of high-flying momementum of the past from athenahealth might still be looking. The cloud-based health services company announced third quarter results Thursday that didn't cause much jubilation but weren't too...
ATHN: 123.34 (-0.48)

athenahealth's (ATHN) CEO Jonathan Bush on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Oct 17, 1:06PM CDT

ATHN: 123.34 (-0.48)

ATHENAHEALTH
at Investor's Business Daily - Thu Oct 16, 5:49PM CDT
ATHENAHEALTH (ATHN) said Q3 EPS fell 6.9% to 27 cents, in line with views. Revenue rose 25.7% to $190.43 bil vs. views for $190.4 bil. Shares fell 2% to 118.05.
ATHN: 123.34 (-0.48)

athenahealth, Inc. Reports Third Quarter Fiscal Year 2014 Results
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Company Announces Record Physician Additions
ATHN: 123.34 (-0.48)

Athenahealth reports 3Q loss
Automated Insights - Thu Oct 16, 3:31PM CDT
WATERTOWN, Mass. (AP) _ Athenahealth Inc. (ATHN) on Thursday reported a loss of $1.6 million in its third quarter.
ATHN: 123.34 (-0.48)

athenahealth revenue up 26%
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 3:28PM CDT

ATHN: 123.34 (-0.48)

Athenahealth EPS and revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 3:03PM CDT

ATHN: 123.34 (-0.48)

Will athenahealth, Inc. (ATHN) Beat Earnings this Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 8:40AM CDT
Our proven model does not conclusively show that athenahealth, Inc. (ATHN) is likely to beat earnings this quarter.
ABAX: 52.75 (+1.12), HTWR: 77.96 (+1.42), HOLX: 26.53 (+0.32), ATHN: 123.34 (-0.48)

Athenahealth Inc. (ATHN) Stock Research Links

ATHN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 12

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 7

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 9

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 7

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 9

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 17

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 15

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched for Block Investors This Spring

Updated Category News Views 119

Investigation By Faruqi & Faruqi, LLP Faruqi & Faruqi, LLP, a prominent national securities litigation firm, is currently looking into issues concerning Block, Inc. (NASDAQ: SQ). The firm is focusing on claims related to alleged violations of federal securities laws that may have resulted in significant losses for investors. If you have experienced a loss of over $75,000...

Continue Reading
Aviat Networks Faces Scrutiny After Annual Report Delay

Updated Category News Views 85

Investor Concerns Escalate Amid Aviat Networks' Delay in Reporting Aviat Networks, Inc. (NASDAQ: AVNW) is facing a tough situation as its stock price suffered a notable decline, falling by $6.36, or around 26%, during intraday trading on a recent date. This drop followed the company's announcement that it would miss the deadline for filing its financial statements for the...

Continue Reading
Tarsus Pharmaceuticals Prepares to Share Q2 2025 Results

Updated Category News Views 243

Anticipating Tarsus Pharmaceuticals' Financial Report Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is gearing up to present its financial results for the second quarter of 2025 during a live webcast slated for Wednesday, August 6, 2025. This event will commence at 1:30 p.m. PT and 4:30 p.m. ET, providing a timely update on the company's performance and strategic...

Continue Reading
Country Garden's Stock Recovers After Debt Restructuring Efforts

Updated Category News Views 135

Country Garden’s Stock Trading Resumes with Momentum Recently, shares of Country Garden (HK: 2007), a prominent name in the Chinese property market, saw an impressive rise as trading resumed in Hong Kong after a lengthy suspension of nine months. This rebound came after the company's notable commitment to creating a debt-restructuring plan aimed at appealing to its...

Continue Reading
Unlocking Long-Term Gains: Insights from Dollar Tree's Success

Updated Category News Views 90

Dollar Tree's Remarkable Growth Over Two Decades Over the last 20 years, Dollar Tree (NASDAQ: DLTR) has become a major player in the retail market, demonstrating incredible resilience and expansion. If someone had put $1,000 into Dollar Tree stock two decades ago, that investment would have surged to more than $7,300 today. This change highlights the effectiveness of...

Continue Reading